Digital Myxoid Cysts: Correlation of Initial and Long-Term Response to Steroid Injections.


Journal

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
ISSN: 1524-4725
Titre abrégé: Dermatol Surg
Pays: United States
ID NLM: 9504371

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 31 3 2021
medline: 14 9 2021
entrez: 30 3 2021
Statut: ppublish

Résumé

Digital mucous cysts (DMCs) are benign myxoid pseudocysts that develop on the distal interphalangeal joint's lateral or dorsal aspects. Management consists either of a surgical approach, conservative therapy, or simple follow-up. To correlate the initial and long-term response with clinical and ultrasound parameters in DMCs treated with intralesional steroids as first-line therapy. A single-center prospective open-label study recruited 15 patients affected by DMCs, who had been treated with a cycle of up to 3 steroid injections at a 6 to 9 week time interval. At the first follow-up visit, 53.3% of patients were cleared of DMCs, achieving a complete response, whereas 46.7% experienced a >30% decrease in their DMC volume, and were considered partial responders. After 1 year of follow-up, the cure rate decreased to 40%, and the recrudescence rate was 27.3%. Clinical and sonographic characteristics that positively correlated with a maintained complete response at follow-up were as follows: young age, absence of osteophytes, low volume, complete clearance at T1, and short disease duration (p < .05). Intralesional steroid therapy is an easy approach for DMC, with minimal side effects; identifying predictive hallmarks is useful to offer a straightforward surgical treatment to patients who have nonresponder characteristics.

Sections du résumé

BACKGROUND
Digital mucous cysts (DMCs) are benign myxoid pseudocysts that develop on the distal interphalangeal joint's lateral or dorsal aspects. Management consists either of a surgical approach, conservative therapy, or simple follow-up.
OBJECTIVE
To correlate the initial and long-term response with clinical and ultrasound parameters in DMCs treated with intralesional steroids as first-line therapy.
METHODS
A single-center prospective open-label study recruited 15 patients affected by DMCs, who had been treated with a cycle of up to 3 steroid injections at a 6 to 9 week time interval.
RESULTS
At the first follow-up visit, 53.3% of patients were cleared of DMCs, achieving a complete response, whereas 46.7% experienced a >30% decrease in their DMC volume, and were considered partial responders. After 1 year of follow-up, the cure rate decreased to 40%, and the recrudescence rate was 27.3%. Clinical and sonographic characteristics that positively correlated with a maintained complete response at follow-up were as follows: young age, absence of osteophytes, low volume, complete clearance at T1, and short disease duration (p < .05).
CONCLUSION
Intralesional steroid therapy is an easy approach for DMC, with minimal side effects; identifying predictive hallmarks is useful to offer a straightforward surgical treatment to patients who have nonresponder characteristics.

Identifiants

pubmed: 33784449
pii: 00042728-202105000-00008
doi: 10.1097/DSS.0000000000002944
doi:

Substances chimiques

Steroids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e146-e152

Informations de copyright

Copyright © 2020 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.

Références

Eliassow A, Frank SB. Pathogenesis of synovial lesions of the skin. Arch Dermatol Syphilol 1942;46:691–4.
Jabbour S, Kechichian E, Haber R, Roland T, et al. Management of digital mucous cysts: a systematic review and treatment algorithm. Int J Dermatol 2017;56:701–8.
Pasch M, Haneke E, Baran R, Thomas L, et al. Tumours of the nail apparatus and adjacent tissues. In: Baran and Dawber's Diseases of the Nails and Their Management (5th ed). Baran R, de Berker D, Holzberg M, Piraccini BM, et al, editors. Oxford, United Kingdom: John Wiley & Sons, Ltd; 2019; pp. 759–762.
Lin YC, Wu YH, Scher RK. Nail changes and association of osteoarthritis in digital myxoid cyst. Dermatol Surg 2008;34:364–9.
Erne HC, Gardner TR, Strauch RJ. Transillumination of hand tumors: a cadaver study to evaluate accuracy and intraobserver reliability. Hand (N Y) 2011;6:390–3.
De Berker D, Goettman S, Baran R. Subungual myxoid cysts: clinical manifestations and response to therapy. J Am Acad Dermatol 2002;46:394–8.
Chae JB, Ohn J, Mun JH. Dermoscopic features of digital mucous cysts: a study of 23 cases. J Dermatol 2017;44:1309–12.
Pellacani G, Alessandrini A, Mandel VD, Martella A, et al. Onychoscopy with red light for vascular pattern identification: a study of 33 patients. J Eur Acad Dermatol Venereol 2019;33:2355–61.
Ferreli C, Caravano M, Fumo G, Rongioletti F. Digital myxoid cysts: 12-year experience from two Italian Dermatology Units. G Ital Dermatol Venereol 2018;153:847–54.
Wang X, Chen H, Sun J. A case of multiple ganglion-type digital myxoid cysts. Int J Dermatol 2020;59:e242–e244.
Weisstein JS. Benign and malignant bone tumors. In: Trumble TE, Budoff JE, editors. Hand Surgery Updates IV. Rosemont, IL: American Society for Surgery of the Hand; 2007.
Henderson MM, Neumeister MW, Bueno RA. Hand tumors: I. Skin and soft-tissue tumors of the hand. Plast Reconstr Surg 2014;133:154e–64e.
Kleinert HE, Kutz JE, Fishman JH, McCraw LH. Etiology and treatment of the so-called mucous cyst of the finger. J Bone Joint Surg Am 1972;54:1455–8.
Fritz GR, Stern PJ, Dickey M. Complications following mucous cyst excision. J Hand Surg Edinb Scotl 1997;22:222–5.
De Berker D, Lawrence C. Ganglion of the distal interphalangeal joint (myxoid cyst): therapy by identification and repair of the leak of joint fluid. Arch Dermatol 2001;137:607–10.
Kim EJ, Huh JW, Park H-J. Digital mucous cyst: a clinical-surgical study. Ann Dermatol 2017;29:69–73.
Lawrence C. Skin excision and osteophyte removal is not required in the surgical treatment of digital myxoid cysts. Arch Dermatol 2005;141:1560–4.
Dodge LD, Brown RL, Niebauer JJ, McCarroll HR. The treatment of mucous cysts: long-term follow-up in sixty-two cases. J Hand Surg 1984;9:901–4.
Drapé JL, Idy-Peretti I, Goettmann S, Salon A, et al. MR imaging of digital mucoid cysts. Radiology 1996;200:531–6.
Gaitini D. Introduction to color Doppler ultrasound of the skin. In: Wortsman X, editor. Dermatologic Ultrasound with Clinical and Histologic Correlations. New York, NY: Springer; 2013; pp. p3–14.
Wortsman X, Jemec G, Villani A. Ultrasound and other imaging methods. In: Baran R, de Berker D, Holzberg M, Piraccini BM, et al, editors. Baran and Dawber's Diseases of the Nails and Their Management (5th ed). Oxford, United Kingdom: John Wiley & Sons, Ltd; 2019; pp. 162–4.
Epstein E. A simple technique for managing digital mucous cysts. Arch Dermatol 1979;115:1315–6.
Rizzo M, Beckenbaugh RD. Treatment of mucous cysts of the fingers: review of 134 cases with minimum 2-year follow-up evaluation. J Hand Surg Am 2003;28:519–24.
Goldman JA, Goldman L, Jaffe MS, Richfield DF. Digital mucinous pseudocysts. Arthritis Rheum 1977;20:997–1002.
Rahim KA. Aspiration alone, aspiration plus steroid injection and aspiration plus ethanol injection for treatment of dorsal wrist ganglions: a comparative study among three methods. J Enam Med Coll 2016;6:19–22.
De Berker DA, Lawrence CM. Treatment of myxoid cysts. Dermatol Surg 2001;27:296–9.
Mathiessen A, Slatkowsky-Christensen B, Kvien TK, Hammer HB, et al. Ultrasound-detected inflammation predicts radiographic progression in hand osteoarthritis after 5 years. Ann Rheum Dis 2016;75:825–30.

Auteurs

Andrea Sechi (A)

Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Michela Starace (M)

Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Aurora Alessandrini (A)

Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Raffaele Dante Caposiena Caro (RD)

Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy.

Bianca Maria Piraccini (BM)

Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH